Oxygen depletion devices and methods for removing oxygen from red blood cells

US9296990B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9296990-B2
Application numberUS-201314038001-A
CountryUS
Kind codeB2
Filing dateSep 26, 2013
Priority dateOct 12, 2009
Publication dateMar 29, 2016
Grant dateMar 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An oxygen depletion device. The device has a cartridge; a plurality of hollow fibers extending within the cartridge from an entrance to an exit thereof; an amount of an oxygen scavenger packed within the cartridge and contiguous to and in between the plurality of hollow fibers. The hollow fibers are adapted to receiving and conveying red blood cells. There is another embodiment of an oxygen depletion device and method for removing oxygen from red blood cells.

First claim

Opening claim text (preview).

What is claimed: 1. A method for adding oxygen to red blood cells comprising: passing red blood cells through an oxygen addition device, wherein said device comprises: a receptacle of a solid material having an inlet and an outlet receiving and expelling a gas; and a plurality of hollow fibers extending within said receptacle from an entrance to an exit thereof, wherein said plurality of hollow fibers receive and convey said red blood cells, wherein said red blood cells are passaged within said hollow fibers. 2. The method of claim 1 , wherein said red blood cells entering said oxygen addition device are oxygen-depleted red blood cells. 3. The method of claim 1 , wherein said gas is pure oxygen. 4. The method of claim 1 , wherein said gas is air. 5. The method of claim 1 , wherein said plurality of hollow fibers are formed from an oxygen-permeable material selected from the group consisting of polyolefin, polytetrafluoroethylene, polyester, polyvinylidene fluoride (PVDF), and polysulfone. 6. The method of claim 1 , wherein said plurality of hollow fibers are formed from a hydrophobic polymer. 7. The method of claim 1 , wherein said plurality of hollow fibers are formed from an inorganic ceramic. 8. The method of claim 1 , wherein said plurality of hollow fibers are configured as a linear spiral, a longitudinal spiral, or a coil. 9. A method for preparing red blood cells for transfusion into a subject in need thereof, comprising: passing red blood cells through an oxygen addition device and transfusing re-oxygenated red blood cells to said subject, wherein said device comprises: a receptacle of a solid material having an inlet and an outlet receiving and expelling a gas; and a plurality of hollow fibers extending within said receptacle from an entrance to an exit thereof, wherein said plurality of hollow fibers receive and convey said red blood cells, wherein said red blood cells are passaged within said hollow fibers. 10. The method of claim 9 , wherein said subject is a patient with inadequate lung capacity to re-oxygenate transfused blood. 11. The method of claim 9 , wherein said subject is a patient with sickle cell anemia. 12. The method of claim 9 , wherein said red blood cells entering said oxygen addition device are oxygen-depleted red blood cells. 13. The method of claim 9 , wherein said gas is pure oxygen. 14. The method of claim 9 , wherein said gas is air. 15. The method of claim 9 , wherein said plurality of hollow fibers are formed from an oxygen-permeable material selected from the group consisting of polyolefin, polytetrafluoroethylene, polyester, polyvinylidene fluoride (PVDF), and polysulfone. 16. The method of claim 9 , wherein said plurality of hollow fibers are formed from a hydrophobic polymer. 17. The method of claim 9 , wherein said plurality of hollow fibers are formed from an inorganic ceramic. 18. The method of claim 9 , wherein said plurality of hollow fibers are configured as a linear spiral, a longitudinal spiral, or a coil.

Assignees

Inventors

Classifications

  • Antianaemics · CPC title

  • Red blood cells; Erythrocytes · CPC title

  • Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging · CPC title

  • C12N5/0641Primary

    Erythrocytes · CPC title

  • Oxygen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9296990B2 cover?
An oxygen depletion device. The device has a cartridge; a plurality of hollow fibers extending within the cartridge from an entrance to an exit thereof; an amount of an oxygen scavenger packed within the cartridge and contiguous to and in between the plurality of hollow fibers. The hollow fibers are adapted to receiving and conveying red blood cells. There is another embodiment of an oxygen dep…
Who is the assignee on this patent?
New Health Sciences Inc, Univ Pittsburgh—Of The Commonwealth System Of Higher Education, Univ Pittsburgh
What technology area does this patent fall under?
Primary CPC classification C12N5/0641. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).